As of May 27
| +0.04 / +1.91%|
The 4 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 9.00, with a high estimate of 16.00 and a low estimate of 3.50. The median estimate represents a +322.54% increase from the last price of 2.13.
The current consensus among 3 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.